A primary indicator of the HSV-2 market potential is the HPV market.
Merck's Gardasil is the leading product with sales of over $3 billion in 2018.
HPV Market Demonstrates the HSV2 Opportunity
Human Papillomavirus Vaccine Global Market - Sales (1)
2019: $ 3.80 billion
2027 Estimate: $12.69 billion
CAGR 2020-2027 16.30 %